Cirmtuzumab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Humanized |
Target | ROR1 |
Clinical data | |
Other names | UC-961 |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
UNII |
Cirmtuzumab (also UC-961) is an anti-ROR1 humanised monoclonal antibody.[1][2]
It is an experimental drug in early-stage clinical trials for various cancers including chronic lymphocytic leukemia (CLL).[3][4]
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.